SUVEN LIFE SCIENCES
Back to Income Statement
|
SUVEN LIFE SCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-105 Cr | ₹-118 Cr | ₹-122 Cr | ₹-72 Cr | ₹-94 Cr |
What is the latest Consolidated Net Profit of SUVEN LIFE SCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-105 Cr |
| Mar2024 | ₹-118 Cr |
| Mar2023 | ₹-122 Cr |
| Mar2022 | ₹-72 Cr |
| Mar2021 | ₹-94 Cr |
How is Consolidated Net Profit of SUVEN LIFE SCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-105 Cr | Negative | |
| Mar2024 | ₹-118 Cr | Negative | |
| Mar2023 | ₹-122 Cr | Negative | |
| Mar2022 | ₹-72 Cr | Negative | |
| Mar2021 | ₹-94 Cr | - | |
Compare Consolidated Net Profit of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹3,376.8 Cr | -3.5% | 9.6% | 26.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -3.5% |
9.6% |
26.1% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses